(NaturalNews)
Wednesday, August 08, 2012
by: Ethan A. Huff

The Financial Times reports that GlaxoSmithKline (GSK), the drug behemoth recently forced to fork over the largest ever amount in fines for its massive criminal conduct (http://www.naturalnews.com), is leading the way in unveiling what the industry is now calling "bioelectronics." The premise holds that certain diseases can be treated by injecting electronic devices within the body for the purpose of artificially controlling neuronal synapses and other activity.
"Moving beyond conventional drugs that interact biochemically with the body, [Big Pharma] will have built a big 'bioelectronics' business that treats disease through electrical signaling in the brain and elsewhere," writes Clive Cookson for FT.com about the concept, which is expected to eventually replace many common drugs. (CONTINUE READING)